PHC Launches Cell-IQ® CO₂ Incubators with Active Humidity Control, Creating Critical Stability for Research Samples

8 hours ago 3
 MCO-233AICUVX-PA, MCO-233AICUVHX-PA, MCO-173AICUVX-PA, and MCO-173AICUVHX-PA) features a patented active hybrid humidification system. The system helps maintain stable culture environments, reduces evaporation across multi-well plates, minimizes edge effect, and reduces condensation.The PHCbi Cell-IQ® CO₂ Incubator Series (model numbers: MCO-233AICUVX-PA, MCO-233AICUVHX-PA, MCO-173AICUVX-PA, and MCO-173AICUVHX-PA) features a patented active hybrid humidification system. The system helps maintain stable culture environments, reduces evaporation across multi-well plates, minimizes edge effect, and reduces condensation. Business Wire

Article content

WOOD DALE, Ill. — PHC Corporation of North America (PHCNA), provider of PHCbi cell culture and sample preservation solutions across North America and Latin America, has introduced a new series of laboratory incubators featuring active hybrid humidification technology and enhanced contamination control. The new Cell-IQ® CO₂ incubator line is designed to deliver improved environmental stability for a wide range of cell culture applications.

Financial Post

THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

SUBSCRIBE TO UNLOCK MORE ARTICLES

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

REGISTER / SIGN IN TO UNLOCK MORE ARTICLES

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account.
  • Share your thoughts and join the conversation in the comments.
  • Enjoy additional articles per month.
  • Get email updates from your favourite authors.

THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account
  • Share your thoughts and join the conversation in the comments
  • Enjoy additional articles per month
  • Get email updates from your favourite authors

Sign In or Create an Account

or

Article content

Article content

“This new generation of PHCbi incubators represents a significant step forward in active humidity control, delivering the stability and precision that researchers need to generate consistent, high-quality data.”

Article content

Article content

Maintaining precise and stable incubation conditions is essential in life science research and drug development to ensure reliable results. Humidity plays a critical role in both cell culture quality and aligning with regulatory guidance. Sensitive and long-term culture samples are particularly vulnerable to media evaporation—commonly known as the “edge effect”—which can result in sample loss and compromise experiment outcomes. Additionally, other incubators with conventional humidity systems are prone to contamination caused by condensation and require lengthy sterilization procedures, leading to operational downtime.

Article content

By signing up you consent to receive the above newsletter from Postmedia Network Inc.

Article content

The new Cell-IQ® CO₂ Incubator Series (model numbers: MCO-233AICUVX-PA, MCO-233AICUVHX-PA, MCO-173AICUVX-PA, and MCO-173AICUVHX-PA) is designed to address these challenges with PHCbi’s active hybrid humidification function. This technology combines active steam generation with an internal humidity sensor to provide precise humidity control at 80–90%, together with a passive water pan system. By rapidly detecting humidity drops caused by chamber door openings and immediately initiating humidification, this system achieves a humidity recovery speed approximately twice as fast as previous models. This helps maintain stable culture environments, reduces evaporation across multi-well plates, and minimizes edge effect. It also reduces condensation when heat-generating analytical instruments are placed inside the chamber.

Article content

To further support contamination control, the incubators feature an interior made of antimicrobial copper-alloy stainless steel, integrated UV-LED sterilization, and hydrogen peroxide (H₂O₂) decontamination technology that enables rapid decontamination cycles in around three hours, allowing labs to maintain sterile conditions while minimizing downtime.

Article content

Additional enhancements include an intuitive graphical user interface, LabSVIFT® Gen 3 connectivity with expanded remote monitoring and system diagnostics, and smart design elements such as an integrated humidity sensor and a field reversible, ergonomic door handle. Together, these features simplify operation, enhance performance visibility, and reduce maintenance demands.

Article content

“This new generation of PHCbi incubators represents a significant step forward in active humidity control, helping deliver the stability and precision that researchers need to generate consistent, high-quality data,” said Joe LaPorte, Chief Innovation Officer at PHCNA. “By addressing long-standing challenges with humidity management and contamination prevention, we’re helping laboratories improve confidence in their results while supporting the future of cell-based research.”

Article content

Article content

The Cell-IQ® CO₂ Incubator Series is engineered for diverse applications, including organoid and cell line development, high-throughput screening, and integration with live-cell imaging systems. Its ability to maintain stable conditions across frequent door openings and extended culture periods makes it well-suited for advanced and long-term workflows.

Article content

With this launch, PHCNA continues its commitment to providing innovative, reliable, and user-focused solutions that advance scientific discovery in research and clinical laboratories. PHCNA is a subsidiary of PHC Holdings Corporation (TOKYO: 6523).

Article content

About PHC Corporation of North America

Article content

PHC Corporation of North America (PHCNA), headquartered in Wood Dale, IL, is a supplier of PHCbi life sciences laboratory solutions. PHCNA empowers scientific advancement by providing technologies that protect and support critical research. PHCbi solutions provided by PHCNA are trusted by researchers across the United States, Canada, and select countries in Latin America for their reliability and innovation.

Article content

PHCNA is part of the Life Sciences Business Unit of PHC Corporation, a global leader in life science laboratory equipment, which offers solutions that enhance every stage of the research workflow—from sample preservation to cell culture to regenerative medicine. PHC Corporation is a proud subsidiary of PHC Holdings Corporation (TOKYO: 6523), based in Tokyo, Japan. www.phchd.com/us/biomedicalAbout PHC Holdings Corporation (PHC Group) PHC Holdings Corporation (TOKYO: 6523) is a global collection of healthcare companies with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries (referred to collectively as PHC Group) include PHC Corporation, Ascensia Diabetes Care, Epredia Holdings Ltd., LSI Medience Corporation, Wemex Corporation and Mediford Corporation. Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, life sciences and diagnostics. PHC Group’s consolidated net sales in FY2025 were JPY 364 billion with global distribution of products and services in more than 125 countries and regions. www.phchd.com

Article content

Article content

Article content

View source version on businesswire.com:

Article content

Article content

logo

Article content

Contacts

Article content

Media Contact

Article content

Article content

Julia Cottrill

Article content

Article content

Article content

Read Entire Article